Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue
- Status
- COMPLETED
- Phase
- N/A
Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Safety Study of Modified Vaccinia Virus to Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo
- Status
- COMPLETED
- Phase
- N/A
A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
MicroRNA Expression and Function in Cutaneous Malignant Melanoma
- Status
- COMPLETED
- Phase
- N/A
Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
- Status
- TERMINATED
- Phase
- PHASE3
Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
- Status
- COMPLETED
- Phase
- N/A
Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells
- Status
- COMPLETED
- Phase
- PHASE1
Vaccination Plus Ontak in Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2